List view / Grid view
The human medicines committee decided that there was significant evidence…
The human medicines committee decided that there was significant evidence to endorse the use of a combination of bamlanivimab and etesevimab in outpatients at high risk of severe COVID-19.
Eli Lilly will provide the US government with vials of…
Eli Lilly will provide the US government with vials of its COVID-19 antibody therapy bamlanivimab (LY-CoV555) if the treatment is granted Emergency Use Authorisation.
Lilly, Merck and Pfizer have announced how they will enable…
Lilly, Merck and Pfizer have announced how they will enable their employees to volunteer in programmes to combat COVID-19 while on base pay.
The International Federation of Pharmaceutical Manufacturers and Associations has announced…
The International Federation of Pharmaceutical Manufacturers and Associations has announced that the biopharma industry has responding swiftly to the COVID-19 pandemic and will further increase its efforts.
Sanofi and Eli Lilly and Company announced an agreement to…
28 May 2014 | By Sanofi
Sanofi and Eli Lilly and Company announced an agreement to pursue regulatory approval of nonprescription Cialis (tadalafil)...
Cognizant, announced that it has been selected by Eli Lilly…
20 January 2011 | By Brands2Life
Cognizant, announced that it has been selected by Eli Lilly and Company...
